|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
216,650,000 |
Market
Cap: |
2.26(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$10.42 - $10.55 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 826 |
Guru Rank Value : 0.5 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Nuvation Bio is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,313,100 |
10,876,200 |
Total Buy Value |
$0 |
$0 |
$6,692,265 |
$13,868,366 |
Total People Bought |
0 |
0 |
1 |
2 |
Total Buy Transactions |
0 |
0 |
3 |
10 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wang Junyuan Jerry |
CEO, ANHEART THERAPEUTICS LTD. |
|
2024-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
550,758 |
550,758 |
|
- |
|
Wang Junyuan Jerry |
CEO, ANHEART THERAPEUTICS LTD. |
|
2024-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,378,989 |
1,378,989 |
|
- |
|
Cui Xiangmin |
|
|
2024-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
6,172,344 |
4,183,002 |
|
- |
|
Sjogren Colleen |
Chief Commercial Officer |
|
2024-03-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
Makunje Moses |
See RemarksOfficer |
|
2023-11-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,612 |
|
- |
|
Biotech Opportunity Gp, Llc |
Director |
|
2023-09-21 |
4/A |
B |
$1.36 |
$72,138 |
I/I |
53,000 |
12,674,775 |
2.1 |
- |
|
Biotech Opportunity Gp, Llc |
Director |
|
2023-09-20 |
4/A |
B |
$1.36 |
$159,490 |
I/I |
117,100 |
12,621,775 |
2.1 |
- |
|
Biotech Opportunity Gp, Llc |
Director |
|
2023-09-19 |
4/A |
B |
$1.26 |
$6,460,637 |
I/I |
5,143,000 |
12,504,675 |
2.1 |
- |
|
Biotech Opportunity Gp, Llc |
Director |
|
2023-02-21 |
4 |
B |
$1.36 |
$72,138 |
I/I |
53,000 |
12,674,775 |
2.1 |
- |
|
Biotech Opportunity Gp, Llc |
Director |
|
2023-02-20 |
4 |
B |
$1.36 |
$159,490 |
I/I |
117,100 |
12,621,775 |
2.1 |
- |
|
Biotech Opportunity Gp, Llc |
Director |
|
2023-02-19 |
4 |
B |
$1.26 |
$6,460,637 |
I/I |
5,143,000 |
12,504,675 |
2.1 |
- |
|
Falberg Kathryn E |
Director |
|
2022-12-05 |
4 |
B |
$1.95 |
$83,962 |
I/I |
43,000 |
250,000 |
2.1 |
- |
|
Falberg Kathryn E |
Director |
|
2022-12-02 |
4 |
B |
$1.98 |
$93,187 |
I/I |
47,000 |
207,000 |
2.1 |
- |
|
Falberg Kathryn E |
Director |
|
2022-12-01 |
4 |
B |
$1.97 |
$167,599 |
I/I |
84,959 |
160,000 |
2.1 |
- |
|
Falberg Kathryn E |
Director |
|
2022-11-30 |
4 |
B |
$1.85 |
$139,088 |
I/I |
75,041 |
75,041 |
2.1 |
- |
|
Omega Fund V Gp Manager, Ltd. |
10% Owner |
|
2022-04-05 |
4 |
S |
$5.60 |
$14,000,000 |
D/D |
(2,500,000) |
20,457,340 |
|
- |
|
Omega Fund V Gp Manager, Ltd. |
10% Owner |
|
2021-12-15 |
4 |
S |
$10.07 |
$5,035,000 |
D/D |
(500,000) |
22,957,340 |
|
- |
|
Omega Fund V Gp Manager, Ltd. |
10% Owner |
|
2021-12-07 |
4 |
S |
$9.80 |
$13,720,000 |
D/D |
(1,400,000) |
23,457,340 |
|
- |
|
Biotech Opportunity Gp, Llc |
Affiliate of Director |
|
2021-11-24 |
4 |
B |
$7.69 |
$1,422,091 |
I/I |
185,026 |
1,169,241 |
0.01 |
- |
|
Omega Fund V Gp Manager, Ltd. |
10% Owner |
|
2021-11-23 |
4 |
S |
$9.75 |
$351 |
D/D |
(36) |
24,857,376 |
|
- |
|
Omega Fund V Gp Manager, Ltd. |
10% Owner |
|
2021-11-22 |
4 |
S |
$9.76 |
$2,879,200 |
D/D |
(295,000) |
24,857,376 |
|
- |
|
Omega Fund V Gp Manager, Ltd. |
10% Owner |
|
2021-11-03 |
4 |
S |
$9.25 |
$18,500,000 |
D/D |
(2,000,000) |
25,152,376 |
|
- |
|
Biotech Opportunity Gp, Llc |
Affiliate of Director |
|
2021-07-31 |
4 |
S |
$8.64 |
$489,007 |
I/I |
(56,598) |
1,147,483 |
|
- |
|
Biotech Opportunity Gp, Llc |
Affiliate of Director |
|
2021-07-31 |
4 |
B |
$8.64 |
$489,007 |
I/I |
56,598 |
7,198,407 |
0.01 |
- |
|
Biotech Opportunity Gp, Llc |
10% Owner |
|
2021-04-13 |
4 |
B |
$10.27 |
$323,537 |
I/I |
31,500 |
1,355,625 |
1.5 |
- |
|
44 Records found
|
|
Page 1 of 2 |
|
|